Friday, 10 Apr 2020

You are here

10 Year Study Identifies Predictors of Skin Progression in Systemic Sclerosis

The European Scleroderma Trials and Research (EUSTAR) cohort has reported the results of their prospective study to identify onset symptoms and risk factors for skin sclerosis and digital ulcers (DUs) in early onset systemic sclerosis (SSc) patients.

695 patients with SSc were enrolled withing within 1 year of the onset of Raynaud’s phenomenon (RP) onset and were followed for 10 years in this prospective, multinational EUSTAR Study.

The median modified Rodnan skin scores (mRSS) peaked 1 year after RP onset with an average score of 15 points. The 1-year probability of developing an mRSS ≥2 in the arms and legs was 69% and 25%

Twenty-five percent of patients developed diffuse cutaneous involvement in the first year after RP onset and increased to 36% during the next 2 years and only 6% developed diffuse cutaneous SSc thereafter.

The probability to digital ulcerations (DUs) increased over time to a maximum of 70% at the end of the 10-year observation. Risk factors for diffuse cutaneous SSc were the presence of anti-RNA polymerase III autoantibodies, antitopoisomerase autoantibodies and male sex. The main risk factor associated with incident DUs was the presence of antitopoisomerase autoantibodies.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

In Lupus, Keep BP Below 130/80

Blood pressure should be maintained at a level below 130/80 mm Hg in all patients with lupus to lessen their likelihood of atherosclerotic vascular events, Canadian researchers asserted.

In Vasculitis, Beware of Infection

Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.

Malignancies with Giant Cell Arteritis

The Journal of Rheumatology reports the findings of a Swedish population-based cohort study of biopsy-proven giant cell arteritis (GCA) patients showing that the overall risk for cancer was not increased; yet there appears to be an increased risk for leukemia and a decreased risk for breast and upper gastrointestinal tract cancers.   

Hospitalized GPA - Higher morbidity, Mortality and Cost

Rheumatology reports on a study of patients with granulomatosis with polyangiitis (GPA) showing worse outcomes and higher costs when hospitalized with GPA.

GPA patients were identified from the Nationwide Inpatient Sample (NIS) and were compared to those without GPA with regard to demographics, procedures, length of stay, mortality, morbidity and total hospitalization charges (between 2005–2014).

Don't Blame the Weather in Sjogren's

Seasonal variations in symptoms -- commonly reported by patients with rheumatic diseases -- were not observed in a large cohort of patients with primary Sjogren's syndrome, French investigators found.